We increased the full-year 2024 dividend to $3.10 per share and announced this morning that we intend to increase our full-year 2025 dividend to $3.20. Today, we issued guidance for 2025 and expect total revenue to increase by a high single-digit percentage and core EPS to increase by low...
AstraZeneca Stock Forecast, AZN stock price prediction. Price target in 14 days: 11028.62 GBX. The best long-term & short-term AstraZeneca share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily AZN exchange price projections: monthly and
We have also confirmed an interim dividend of $0.93, reflecting the Board’s intention to increase the dividend to $2.90 for the full year of 2022. Looking across our business, we delivered revenue growth from all disease areas, reflecting not only the breadth of our portfolio, but also the...
AstraZeneca Announces Share Capital and Voting Rights Update Jan 2, 2025 • TipRanks Stocks Achilles Therapeutics sells technology assets to AstraZeneca for $12M Dec 24, 2024 • TipRanks Stocks AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU Dec 24, 2024 ...
Dividend168p Ex-Dividend DateFeb 20, 2025 Short InterestN/A % of Float ShortedN/A Average Volume2.77M Recent News AstraZeneca: Camizestrant Improved PFS in 1L HR+ Breast Cancer Feb. 26, 2025 at 2:40 a.m. ET AstraZeneca Sales, Core EPS Seen Rising -- Earnings Preview ...
Themes: Dividend Stocks Latest on AZN: AstraZeneca: Still One Of The Best Big Pharma Picks iREIT®+HOYA Capital 4.8Hoya Capital Themes: REITs Income Latest on AZN: AstraZeneca: Still One Of The Best Big Pharma Picks (Kody Kester)
Dividend Yield EBIT EBITDA Employees EPS Earnings Per Share Equity Capital and Reserves Gross Profit on Sales Interest Expense on Debt Interest Income Loan Capital Market Capitalization Net Income Operating Expenses Operating Profit Ordinary Share Capital PE Price to Earnings Pre-...
Dividend Per Share view ratings view ratings view ratings view ratings view ratings $2.80 $2.80 $2.87 $2.90 $2.90 $2.97 Payout Ratio view ratings view ratings view ratings view ratings view ratings 269.06% 111.76% 3,442.86% 132.73% 75.25% 71.25...
Net debt increased by $3.8 billion, mainly reflecting the acquisitions completed earlier this year, and $4.6 billion in dividend payments. Our net debt-to-EBITDA ratio currently stands at 1.8 times. As previously indicated, finance expenses are expected to be higher in 2024, compared to...
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript AZN earnings call for the period ending March 31, 2024. Motley Fool Transcribing | Apr 25, 2024 Related Stocks NASDAQ: VRTX Vertex Pharmaceuticals Market Cap $118B Current Price $459.00 ...